A detailed history of Nordea Investment Management Ab transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nordea Investment Management Ab holds 342,429 shares of VRTX stock, worth $147 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
342,429
Previous 286,690 19.44%
Holding current value
$147 Million
Previous $133 Million 3.42%
% of portfolio
0.15%
Previous 0.16%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 06, 2025

BUY
$396.64 - $516.74 $22.1 Million - $28.8 Million
55,739 Added 19.44%
342,429 $138 Million
Q3 2024

Nov 05, 2024

SELL
$460.0 - $505.78 $30.6 Million - $33.7 Million
-66,545 Reduced 18.84%
286,690 $133 Million
Q2 2024

Aug 08, 2024

BUY
$392.81 - $485.53 $8.55 Million - $10.6 Million
21,766 Added 6.57%
353,235 $166 Million
Q1 2024

May 02, 2024

BUY
$407.69 - $446.08 $4.13 Million - $4.52 Million
10,138 Added 3.16%
331,469 $139 Million
Q4 2023

Jan 10, 2024

BUY
$343.0 - $410.68 $3.86 Million - $4.62 Million
11,259 Added 3.63%
321,331 $131 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $7.15 Million - $7.66 Million
21,134 Added 7.31%
310,072 $108 Million
Q2 2023

Jul 07, 2023

BUY
$314.42 - $351.91 $6.51 Million - $7.29 Million
20,712 Added 7.72%
288,938 $102 Million
Q1 2023

Apr 19, 2023

SELL
$283.23 - $323.1 $8.82 Million - $10.1 Million
-31,134 Reduced 10.4%
268,226 $84.5 Million
Q4 2022

Feb 08, 2023

BUY
$285.76 - $321.48 $7.6 Million - $8.55 Million
26,599 Added 9.75%
299,360 $86.4 Million
Q3 2022

Oct 19, 2022

BUY
$273.83 - $305.53 $6.17 Million - $6.88 Million
22,523 Added 9.0%
272,761 $79.6 Million
Q2 2022

Aug 09, 2022

SELL
$234.96 - $292.55 $4.57 Million - $5.69 Million
-19,466 Reduced 7.22%
250,238 $69.7 Million
Q1 2022

Apr 11, 2022

BUY
$221.42 - $260.97 $600,048 - $707,228
2,710 Added 1.02%
269,704 $69.6 Million
Q4 2021

Jan 20, 2022

BUY
$177.01 - $223.45 $5.28 Million - $6.66 Million
29,813 Added 12.57%
266,994 $59.4 Million
Q3 2021

Nov 01, 2021

SELL
$181.39 - $202.99 $43 Million - $48.1 Million
-237,181 Reduced 50.0%
237,181 $43.7 Million
Q3 2021

Nov 01, 2021

BUY
$181.39 - $202.99 $47.5 Million - $53.1 Million
261,745 Added 123.11%
474,362 $86 Million
Q2 2021

Jul 16, 2021

BUY
$187.49 - $221.1 $3.77 Million - $4.44 Million
20,091 Added 10.44%
212,617 $42.9 Million
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $11.1 Million - $12.9 Million
53,501 Added 38.48%
192,526 $41.3 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $6.71 Million - $8.95 Million
32,422 Added 30.41%
139,025 $32.9 Million
Q3 2020

Nov 09, 2020

SELL
$255.65 - $303.1 $18.8 Million - $22.2 Million
-73,389 Reduced 40.77%
106,603 $29 Million
Q2 2020

Aug 13, 2020

BUY
$225.48 - $295.8 $27.1 Million - $35.5 Million
120,034 Added 200.2%
179,992 $52.3 Million
Q1 2020

May 15, 2020

SELL
$199.77 - $247.81 $311,840 - $386,831
-1,561 Reduced 2.54%
59,958 $13.9 Million
Q4 2019

Feb 11, 2020

BUY
$166.71 - $223.91 $935,743 - $1.26 Million
5,613 Added 10.04%
61,519 $13.4 Million
Q3 2019

Nov 13, 2019

BUY
$166.23 - $187.09 $152,266 - $171,374
916 Added 1.67%
55,906 $9.4 Million
Q2 2019

Aug 14, 2019

BUY
$164.61 - $190.37 $1.32 Million - $1.53 Million
8,031 Added 17.1%
54,990 $10.1 Million
Q1 2019

May 20, 2019

BUY
$163.73 - $194.7 $5.42 Million - $6.45 Million
33,119 Added 239.3%
46,959 $8.64 Million
Q4 2018

Feb 14, 2019

BUY
$151.91 - $192.21 $1,519 - $1,922
10 Added 0.07%
13,840 $2.29 Million
Q3 2018

Nov 14, 2018

SELL
$167.73 - $192.74 $618,923 - $711,210
-3,690 Reduced 21.06%
13,830 $2.67 Million
Q2 2018

Aug 13, 2018

BUY
$145.72 - $169.96 $768,673 - $896,539
5,275 Added 43.08%
17,520 $2.98 Million
Q1 2018

May 14, 2018

SELL
$151.6 - $177.13 $10,005 - $11,690
-66 Reduced 0.54%
12,245 $2 Million
Q4 2017

Feb 12, 2018

SELL
$137.28 - $155.55 $45,439 - $51,487
-331 Reduced 2.62%
12,311 $1.85 Million
Q3 2017

Nov 09, 2017

BUY
$148.13 - $162.24 $1.87 Million - $2.05 Million
12,642
12,642 $1.92 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $110B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.